首页> 外国专利> Hydrazide substrate safely shuts down disease activated protease to halt viral replication, cancerous cell division, and toxic protein generation

Hydrazide substrate safely shuts down disease activated protease to halt viral replication, cancerous cell division, and toxic protein generation

机译:酰肼底物可安全关闭疾病激活的蛋白酶,从而阻止病毒复制,癌细胞分裂和有毒蛋白质生成

摘要

A hydrazide substrate is targeted by disease activated protease to shutdown protein products required by viral infections, cancer, and other diseases. Protease cleavage innately targets peptide bonds that are simulated in the hydrazide substrate molecule. Cleavage action releases the reactive hydrazine moiety that bonds to the protease enzyme structure causing its dysfunctional shutdown. That shutdown stops incessant disease activity that holds cell maintenance systems at bay, and also halts the production of proteins and peptides necessary for disease activity and proliferation as viral coat proteins and metastatic cancer proteins exemplify. Other uses for the hydrazide substrates mechanism also exists to shutdown protease systems innate to microorganisms as a way to halt production of peptide signals that induced cell division, growth, or reproduction of infectious organisms.
机译:酰肼底物被疾病激活的蛋白酶靶向,以关闭病毒感染,癌症和其他疾病所需的蛋白质产物。蛋白酶切割固有地靶向在酰肼底物分子中模拟的肽键。切割作用释放了与蛋白酶结构键合的反应性肼部分,导致其功能失调。这种关闭停止了持续不断的疾病活动,使细胞维持系统停滞不前,并且由于病毒外壳蛋白和转移性癌蛋白的出现,也停止了疾病活动和增殖所必需的蛋白质和肽的产生。酰肼底物机制的其他用途还可以关闭微生物固有的蛋白酶系统,以停止产生诱导感染性生物的细胞分裂,生长或繁殖的肽信号。

著录项

  • 公开/公告号US2004198840A1

    专利类型

  • 公开/公告日2004-10-07

    原文格式PDF

  • 申请/专利权人 DELOACH REUBEN EDWIN;

    申请/专利号US20040813384

  • 发明设计人 REUBEN EDWIN DELOACH;

    申请日2004-03-30

  • 分类号A61K31/15;

  • 国家 US

  • 入库时间 2022-08-21 23:19:40

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号